Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pharmacia and Upjohn
Patients are divided into 2 treatment groups; the groups are balanced with respect to viral load. Group A receives ZDV, DLV, and IDV 3 times daily. Group B receives ZDV, DLV, and IDV 2 times daily. Patients are evaluated for changes from baseline in viral load and CD4 cell count.
Age
14–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
You may be eligible for this study if you:
Are HIV-positive.
Have a viral load (level of HIV in the blood) of at least 20,000 copies/ml.
Have a CD4 cell count of at least 50 cells/mm3.
Are at least 14 years old (consent of parent or guardian is required if under 18).
You may not be if
You will not be eligible for this study if you:
Have ever taken an anti-HIV drug other than ZDV.
Have taken ZDV for more than 1 month.
Clareo Health | A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients
